- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07305038
EDLS-clips in Endoscopic Full-thickness Resection
December 12, 2025 updated by: Mingliang Feng, First Hospital of China Medical University
Analysis of the Clinical Effect of EDLS-clips in Endoscopic Full-thickness Resection
A retrospective analysis was conducted on patients who visited from March 2022 to May 2024 and underwent endoscopic full-thickness resection and double-layer suture with titanium clips under endoscopy.
The basic clinical information, tumor characteristics, overall resection rate and postoperative complications of all patients were evaluated.
To analyze the clinical effect of double-layer suture technique with titanium clips under endoscopy in clamping the wound surface after full-thickness endoscopic resection.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The clinical data of patients who underwent endoscopic double-layer suture with titanium clip after endoscopic full-thickness resection at the Endoscopy Center of the First Affiliated Hospital of China Medical University from March 2022 to May 2024 were collected.
Indications for endoscopic treatment of SMT: ① For tumors suspected of having malignant potential through preoperative examination or confirmed by biopsy pathology, especially for those suspected of having GIST with a preoperative long diameter of ≤2cm, low risk of recurrence and metastasis, and possibly complete resection, endoscopic resection can be performed.
For suspected low-risk GIST with a tumor long diameter greater than 2cm and preoperative assessment excluding lymph node or distant metastasis, under the premise of ensuring complete tumor resection, endoscopic resection can be considered to be carried out by experienced endoscopists in units with mature endoscopic treatment techniques.
② SMT with symptoms (such as bleeding, obstruction).
③ Patients who are suspected of being benign by preoperative examination or confirmed by pathology, but cannot be followed up regularly or whose tumors increase in a short period of time during the follow-up period, or who have a strong willingness for endoscopic treatment.
When the tumor protrudes into the serosa or partially grows outside the cavity, or when it is found during the operation that the tumor is closely adhered to the serosa layer and cannot be separated, EFTR can be selected for endoscopic treatment.
Complications related to SMT in endoscopic treatment: (1) Intraoperative bleeding: Bleeding that causes the patient's hemoglobin to drop by more than 20g/L.
(2) Postoperative bleeding: Postoperative bleeding is manifested as hematemesis, melena or hematochezia, etc.
In severe cases, there may be manifestations of hemorrhagic shock.
It mostly occurs within one week after the operation, but it can also appear 2 to 4 weeks after the operation.
(3) Delayed perforation: It is usually manifested as abdominal distension, aggravated abdominal pain, signs of peritonitis, fever, and imaging examination shows gas accumulation or an increase in gas accumulation compared to before.
(4) Gas-related complications: including subcutaneous emphysema, mediastinal emphysema, pneumothorax and pneumoperitoneum, etc. (5) Digestive tract fistula: Digestive juices caused by endoscopic surgery flow into the thoracic or abdominal cavity through the leakage channel.
From a patient's medical records collected in the patient's age, gender, lesion characteristics, endoscopic treatment and postoperative clinical course details and other information.
The investigators define the position of the lesion on the short axis as the position of the lesion center.
The closure time is defined as the period from the start (when the investigators insert the clamp into the visual field channel) to the end of closure (when the last clamp is released).
Study Type
Observational
Enrollment (Actual)
43
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Liaoning
-
Shenyang, Liaoning, China, 110001
- The First Hospital of China Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This study comprises case series of 43 patients with gastric SMTs who underwent EDLS-clips after EFTR in our center from March 2022 to May 2024.
Description
Inclusion Criteria:
- Having a tumor located in the stomach and confirmed to originate from the muscularis propria on endoscopic ultrasonography (EUS);
- Having a tumor diameter >1 cm, which can be completely resected using endoscopic techniques, and with low risk of residue and recurrence;
- Preoperative assessment excluded those with lymph node or distant metastasis;
- Being able to tolerate tracheal intubation anesthesia, with no coagulation dysfunction or anticoagulant drugs stopped before EFTR.
Exclusion Criteria:
- Patients who have been evaluated preoperatively and are considered to have lymph node or distant metastasis;
- who cannot tolerate general anesthesia with endotracheal intubation,
- who have not discontinued anticoagulant drugs before EFTR or have coagulation dysfunction.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The complete closure rate of EDLS-clips
Time Frame: Perioperative/Periprocedural
|
Successful closure refers to the full coverage of the mucosal defect by surrounding normal mucosa without any gaps.
|
Perioperative/Periprocedural
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative time
Time Frame: Perioperative/Periprocedural
|
Operative time refers to the duration of the entire tumor resection and suture process (from the first incision of the mucosa with the knife to the completion of wound closure).
|
Perioperative/Periprocedural
|
|
Suturing time
Time Frame: Perioperative/Periprocedural
|
Suturing time was defined as the period from when the operator inserts the first metallic clip through the instrument channel to close the wound until the release of the final metallic clip (for cases involving simultaneous cutting and suturing, the suturing time includes part of the tumor resection time).
|
Perioperative/Periprocedural
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2022
Primary Completion (Actual)
May 31, 2024
Study Completion (Actual)
May 31, 2025
Study Registration Dates
First Submitted
September 24, 2025
First Submitted That Met QC Criteria
December 12, 2025
First Posted (Actual)
December 26, 2025
Study Record Updates
Last Update Posted (Actual)
December 26, 2025
Last Update Submitted That Met QC Criteria
December 12, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- End-D-F1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Investigators share the technical operation of this endoscopic double-layer suture method for closing the wounds after endoscopic full-thickness resection (EFTR) for gastric submucosal tumors (SMTs) using endoscopic double-layer suturing method using metal clips (EDLS-clips).
This study included 43 patients with gastric SMTs who received EFTR and were treated with EDLS-clips from March 2022 to May 2024 at our center.
The primary outcome was the complete closure rate by EDLS-clips.
Secondary outcomes included closure time, the number of clips used, and adverse events.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Submucosal Tumors
-
First Affiliated Hospital Xi'an Jiaotong UniversityAir Force Military Medical University, ChinaUnknown
-
Xijing HospitalCompletedGastrointestinal Submucosal Tumors
-
Kliniken Ludwigsburg-Bietigheim gGmbHOvesco Endoscopy AGUnknownColorectal Adenomas | Submucosal TumorsGermany
-
Qilu Hospital of Shandong UniversityQianfoshan Hospital; Shandong Second Provincial General HospitalNot yet recruitingEndoscopic Submucosal Dissection | Endoscopic Submucosal Dissection (ESD)
-
Shandong UniversityRecruitingEarly Gastric Cancer | Endoscopic Submucosal Dissection | Robot SurgeryChina
-
Yonsei UniversityCompletedEarly Gastric Cancer Patients Who Were Scheduled for Endoscopic Submucosal DissectionKorea, Republic of
-
Second Affiliated Hospital, School of Medicine,...RecruitingEarly Gastric Cancer | Endoscopic Submucosal DissectionChina
-
University of FloridaRecruitingEndoscopic Submucosal DissectionUnited States
-
Hôpital Edouard HerriotCompleted
-
Soonchunhyang University HospitalCompletedGastric Neoplasm | Endoscopic Submucosal DissectionKorea, Republic of